CMS Adds Bidding Pressures to Diabetes Devices, But It Won’t Be All Bad
CMS is moving forward with plans to institute competitive bidding for continuous glucose monitors and insulin pumps. The reaction from industry has been largely negative, with pricing pressures a top concern. But there could be substantial upside if the program’s lower out-of-pocket costs drive more Medicare patients to pump therapy.
Read Article